A team of biochemists at the Manchester Institute of Biotechnology has developed an isothermal biocatalytic process that can be used to manufacture therapeutic oligonucleotides in large volumes.

The study, published in Science, combines biocatalytic carbon-hydrogen oxidation and radical cross-coupling, offering a streamlined and cost-effective approach to creating complex, three ...

The study, published in Science, combines biocatalytic carbon-hydrogen oxidation and radical cross-coupling, offering a streamlined and cost-effective approach to create complex, three-dimensional ...

For the development of innovative biocatalytic approaches to produce therapeutic oligonucleotides. A highlight of my career was receiving a prestigious UKRI Future Leader Fellowship, which allowed me ...